Mixlab, which runs a pet pharmacy, has raised $10 million in an extended Series A round led by New York-based Vanterra Ventures, with participation from Lakehouse Ventures. Its regular Series A round in 2021 fetched $20 million.
So far, the six-year-old New York startup has raised $40.5 million. Its other investors include Brand Foundry, Monogram Capital, Sonoma Brands Capital, Global Founders Capital, Mars Petcare and Gyan Kapur of Surface Ventures.
“Mixlab is the first modern veterinary pharmacy that focuses on creating custom medications and delightful experiences for pets, their parents and veterinarians,” Mixlab co-founder and CEO Fred Dijols, who spent a decade as R&D engineer at Johnson and Johnson, wrote on LinkedIn.
“Everything we do is designed to bring joy when pet parents need it most: from easy-to-administer treats and thoughtful packaging to clear instructions and labeling,” added Dijols, who has degrees in science, engineering and business from Harvard and Stanford universities.
Ellis Fried, vice president of Vanterra Ventures, joined Mixlab’s board of directors subsequent to the investment.
Over the past year, Mixlab’s sales have grown 50%, TechCrunch said in a report. The new funding will help the company open services in Miami, Fla., adding to New York and Los Angeles markets.
“On the sales and marketing side, we’ve got a playbook that works on the operation side, and we know how to create a new facility and contribution margins,” Dijols told TechCrunch. Mixlab also hired George Koveos, a senior executive at telehealth firm Ro, as chief operating officer.
Commercial Real Estate
MacKenzie Companies
Advertising / Media / Communications / Public Relations
Nevins & Associates
Financial Services / Investment Firms
Chesapeake Corporate Advisors
Commercial Real Estate
Monday Properties
Venture Capital
Blue Delta Capital Partners
Internet / Technology
Foxtrot Media
Mixlab has built technology to help veterinarians digitally write and manage prescriptions, and for pet owners to monitor delivery in all 50 states.
New York-based Vanterra Ventures has so far made 33 portfolio investments from its fund pool of $150 million, and exited four. Its recent investments include Nano Technologies, Ethlas and Finverse.
Lakehouse Ventures, also based in New York, has made 29 portfolio investments and exited two, investing from a pool of $18.4 million raised via three funds. Its recent investments include Guaranteed, Ours and Courted.
